During the last session, Alzamend Neuro Inc (NASDAQ:ALZN)’s traded shares were 0.32 million, with the beta value of the company hitting -0.17. At the end of the trading day, the stock’s price was $0.66, reflecting an intraday gain of 21.87% or $0.12. The 52-week high for the ALZN share is $15.06, that puts it down -2181.82 from that peak though still a striking 22.73% gain since the share price plummeted to a 52-week low of $0.51. The company’s market capitalization is $4.35M, and the average trade volume was 408.12K shares over the past three months.

Alzamend Neuro Inc (ALZN) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.00. ALZN has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.3.

Alzamend Neuro Inc (NASDAQ:ALZN) trade information

Alzamend Neuro Inc (ALZN) registered a 21.87% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 21.87% in intraday trading to $0.66, hitting a weekly high. The stock’s 5-day price performance is -1.78%, and it has moved by -17.22% in 30 days. Based on these gigs, the overall price performance for the year is -88.31%.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -11.45%. While earnings are projected to return 89.05% in 2025, the next five years will return 61.95% per annum.

ALZN Dividends

Alzamend Neuro Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Also, the Mutual Funds coming in first place with the largest holdings of Alzamend Neuro Inc (ALZN) shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . Data provided on Mar 31, 2025 indicates that Fidelity Concord Street Trust-Fidelity Extended Market Index Fund owns about 30.01 shares. This amounts to just over 0.45 percent of the company’s overall shares, with a $19747.0 market value. The same data shows that the other fund manager holds slightly less at 7.85, or about 0.12% of the stock, which is worth about $5168.0.